Leonor Beatriz Suarez

Business & Professional Services

• Slate Asset Management in its joint venture with Jones Lang LaSalle, a commercial real estate broker and property manager
• CIVC Partners in its investment in HR Green, a provider of infrastructure design, engineering, and consulting services
• Oaktree Capital Management-backed WHP Global, a brand management firm, in its $375 million investment from Ares Management Corp. (NYSE: ARES)

Healthcare & Life Sciences

• GTCR in its $627 million acquisition of Surmodics (NASDAQ: SRDX), a provider of medical device and in vitro diagnostic technologies
• Carlyle Group, Inc. (NASDAQ: CG) on the $3.8 billion acquisition of global medtech company Baxter International Inc.’s (NYSE:BAX) kidney care segment, which will be named Vantive. Carlyle’s investment in Vantive is being made in partnership with Atmas Health, a collaboration among three industry executives founded in September 2022 to focus on acquiring and building a market-leading healthcare business
• Biopharmaceutical company, on its acquisition of a private biotechnology company with a portfolio of assets for well-validated targets in oncology and inflammation
• Eli Lilly and Company (NYSE: LLY) in its:
  
  • $610 million acquisition of Akouos (NASDAQ: AKUS), a precision genetic medicine company that is developing a portfolio of first-in-class adeno-associated viral gene therapies for the treatment of inner ear conditions
  • $1.4 billion acquisition of POINT Biopharma (NASDAQ: PNT), a radiopharmaceutical company
• Investment bank in the auction of its portfolio company, a full-service clinical research organization that provides pre-clinical and later-stage clinical development services to biotechnology and pharmaceutical companies
• Oak Street Health (NYSE: OSH), a primary care company, in its pending $10.6 billion sale to CVS Health (NYSE: CVS)
• Pharmaceutical Company in their acquisition of a private German biopharmaceutical company developing novel antibody drug conjugates
• Private equity firm in the acquisition of a biopharmaceutical company that develops and manufactures drugs

Industrials & Manufacturing

• Power & Digital Infrastructure Acquisition II Corp. (NASDAQ: XPDB, XPDBW, XPDBU), a special purpose acquisition company, in its $500 million business combination with Montana Technologies, a provider of renewable energy and cooling technology
• Private equity firm on the divestiture of a leading technology provider for firearm identification and 3D microscopy

Software & Services

• Instructure (NYSE: INST), a provider of a learning ecosystem, in its $4.8 billion sale to KKR Software & Services
• THL-backed CARET in the sale of HotDocs, its enterprise document automation and assembly business, to Mitratech
• KORE Group Holdings, Inc. on its definitive agreement to acquire the IoT business of Twilio, Inc., in exchange for 10 million shares of KORE's common stock
• Private equity company in acquisition of a product engineering company that builds software for companies
• SPAC in its deSPAC acquisition of a developer and provider of the proprietary SADAR environmental data analytics platform that assists public and private clients in making policy decisions based on compiled environmental data